ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕

Considering Clinical Trials: A Blog About Cancer Treatment Options
November 3, 2025
November 3, 2025
Categories
  • Editorials

Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials

An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
Do you like it?
0 Read more
November 3, 2025
November 3, 2025
Categories
  • Editorials

What a difference patients make: Honoring the impact of cancer clinical trial participants

ECOG-ACRIN’s Trial Results Summaries Project aims to inform participants of study findings and express gratitude for their contributions to cancer research
Do you like it?
0 Read more
November 3, 2025
November 3, 2025
Categories
  • New Trials

Now Enrolling: The EAA241 research study is exploring a new treatment approach for patients with newly diagnosed myeloma and kidney failure

This clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
Do you like it?
0 Read more
November 3, 2025
Patient and doctor talking over clipboard
November 3, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions

For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
Do you like it?
0 Read more
November 3, 2025
Research dictionary entry
November 3, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Fall 2025

The latest discoveries from breast, leukemia, lung, nose/sinus, skin, and throat cancer clinical trials
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc